Intracranial vascular pathology in two further patients with Floating-Harbor syndrome: Proposals for cerebrovascular disease risk management

Aravind, 1998, AT-hook motifs identified in a wide variety of DNA-binding proteins, Nucleic Acids Res., 26, 4413, 10.1093/nar/26.19.4413 Bober, 2010, Majewski osteodysplastic primordial dwarfism type II (MOPD II): expanding the vascular phenotype, Am. J. Med. Genet., 152A, 960, 10.1002/ajmg.a.33252 Brinjikji, 2016, Risk factors for growth of intracranial aneurysms: a systematic review and meta-analysis, AJNR Am J Neuroradiol, 37, 615, 10.3174/ajnr.A4575 Clapier, 2009, The biology of chromatin remodeling complexes, Annu. Rev. Biochem., 78, 273, 10.1146/annurev.biochem.77.062706.153223 Coughlin, 2017, Treatment of moyamoya disease and unruptured intracranial aneurysm in floating-harbor syndrome, World Neurosurg, 104, 1049 e1, 10.1016/j.wneu.2017.05.083 Eissenberg, 2005, Human SRCAP and Drosophila melanogaster DOM are homologs that function in the notch signaling pathway, Mol. Cell. Biol., 25, 6559, 10.1128/MCB.25.15.6559-6569.2005 Fischer, 2013, Cervical artery dissection in a young patient with Rubinstein-Taybi syndrome, Clin. Neuroradiol., 23, 41, 10.1007/s00062-011-0100-7 Hood, 2012, Mutations in SRCAP, encoding SNF2-related CREBBP activator protein, cause Floating-Harbor syndrome, Am. J. Hum. Genet., 90, 308, 10.1016/j.ajhg.2011.12.001 Inagawa, 1990, Autopsy study of unruptured incidental intracranial aneurysms, Surg. Neurol., 34, 361, 10.1016/0090-3019(90)90237-J Johnston, 1999, Identification of a novel SNF2/SWI2 protein family member, SRCAP, which interacts with CREB-binding protein, J. Biol. Chem., 274, 16370, 10.1074/jbc.274.23.16370 Komotar, 2008, Guidelines for the surgical treatment of unruptured intracranial aneurysms: the first annual J. Lawrence pool memorial research symposium--controversies in the management of cerebral aneurysms, Neurosurgery, 62, 183, 10.1227/01.NEU.0000311076.64109.2E Messina, 2016, When chromatin organisation floats astray: the Srcap gene and Floating-Harbor syndrome, J. Med. Genet., 53, 793, 10.1136/jmedgenet-2016-103842 Monroy, 2003, SNF2-related CBP activator protein (SRCAP) functions as a coactivator of steroid receptor-mediated transcription through synergistic interactions with CARM-1 and GRIP-1, Mol. Endocrinol., 17, 2519, 10.1210/me.2003-0208 Munot, 2011, Paediatric stroke: genetic insights into disease mechanisms and treatment targets, Lancet Neurol., 10, 264, 10.1016/S1474-4422(10)70327-6 Nikkel, 2013, The phenotype of Floating-Harbor syndrome: clinical characterization of 52 individuals with mutations in exon 34 of SRCAP, Orphanet J. Rare Dis., 8, 63, 10.1186/1750-1172-8-63 Oshino, 2013, Prevalence of cerebral aneurysm in patients with acromegaly, Pituitary, 16, 195, 10.1007/s11102-012-0404-x Paluzzi, 2008, Ruptured cerebral aneurysm in a patient with Floating-Harbor syndrome, Clin. Dysmorphol., 17, 283, 10.1097/MCD.0b013e328306a38d Patton, 1991, Floating-Harbor syndrome, J. Med. Genet., 28, 201, 10.1136/jmg.28.3.201 Perry, 2013, Screening for cerebrovascular disease in microcephalic osteodysplastic primordial dwarfism type II (MOPD II): an evidence-based proposal, Pediatr. Neurol., 48, 294, 10.1016/j.pediatrneurol.2012.12.010 Raps, 1993, The clinical spectrum of unruptured intracranial aneurysms, Arch. Neurol., 50, 265, 10.1001/archneur.1993.00540030031010 Reschen, 2012, Floating-Harbor syndrome and polycystic kidneys associated with SRCAP mutation, Am. J. Med. Genet., 158A, 3196, 10.1002/ajmg.a.35635 Tumialan, 2006, Alagille syndrome and aneurysmal subarachnoid hemorrhage. Case report and review of the literature, Pediatr. Neurosurg., 42, 57, 10.1159/000089512 White, 2010, The phenotype of Floating-Harbor syndrome in 10 patients, Am. J. Med. Genet., 152A, 821, 10.1002/ajmg.a.33294 Wiebers, 2003, Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment, Lancet, 362, 103, 10.1016/S0140-6736(03)13860-3 Wilson, 2016, Pathophysiology of aortic aneurysm: insights from human genetics and mouse models, Pharmacogenomics, 17, 2071, 10.2217/pgs-2016-0127